Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Characteristics influencing expected cognitive performance during hypoglycaemia in type 2 diabetes.

Petersen JZ, Nilsson M, Rungby J, Miskowiak KW.

Psychoneuroendocrinology. 2019 Dec;110:104431. doi: 10.1016/j.psyneuen.2019.104431. Epub 2019 Sep 4.

PMID:
31536941
2.

Risk of dementia and cognitive dysfunction in individuals with diabetes or elevated blood glucose.

Wium-Andersen IK, Rungby J, Jørgensen MB, Sandbæk A, Osler M, Wium-Andersen MK.

Epidemiol Psychiatr Sci. 2019 Aug 28:1-9. doi: 10.1017/S2045796019000374. [Epub ahead of print]

PMID:
31455437
3.

Antidiabetic medication and risk of dementia in patients with type 2 diabetes: a nested case-control study.

Wium-Andersen IK, Osler M, Jørgensen MB, Rungby J, Wium-Andersen MK.

Eur J Endocrinol. 2019 Nov;181(5):499-507. doi: 10.1530/EJE-19-0259.

PMID:
31437816
4.

Sequencing reveals protective and pathogenic effects on development of diabetes of rare GLIS3 variants.

Sun J, Have CT, Hollensted M, Grarup N, Linneberg A, Pedersen O, Nielsen JS, Rungby J, Christensen C, Brandslund I, Kristiansen K, Jun W, Hansen T, Gjesing AP.

PLoS One. 2019 Aug 15;14(8):e0220805. doi: 10.1371/journal.pone.0220805. eCollection 2019.

5.

Multiple Soluble Components of the Glycocalyx Are Increased in Patient Plasma After Ischemic Stroke.

DellaValle B, Hasseldam H, Johansen FF, Iversen HK, Rungby J, Hempel C.

Stroke. 2019 Oct;50(10):2948-2951. doi: 10.1161/STROKEAHA.119.025953. Epub 2019 Aug 14.

PMID:
31409270
6.

Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.

Nilsson M, Jensen N, Gejl M, Bergmann ML, Storgaard H, Zander M, Miskowiak K, Rungby J.

Diabetologia. 2019 Oct;62(10):1948-1958. doi: 10.1007/s00125-019-4964-4. Epub 2019 Jul 31.

PMID:
31367958
7.

The zinc transporter Zip14 (SLC39a14) affects Beta-cell Function: Proteomics, Gene expression, and Insulin secretion studies in INS-1E cells.

Maxel T, Smidt K, Petersen CC, Honoré B, Christensen AK, Jeppesen PB, Brock B, Rungby J, Palmfeldt J, Larsen A.

Sci Rep. 2019 Jun 13;9(1):8589. doi: 10.1038/s41598-019-44954-1.

8.

Increased frequency of rare missense PPP1R3B variants among Danish patients with type 2 diabetes.

Niazi RK, Sun J, Have CT, Hollensted M, Linneberg A, Pedersen O, Nielsen JS, Rungby J, Grarup N, Hansen T, Gjesing AP.

PLoS One. 2019 Jan 10;14(1):e0210114. doi: 10.1371/journal.pone.0210114. eCollection 2019.

9.

[The effect of hyper- and hypoglycaemia on cognition and development of dementia for patients with diabetes mellitus Type 2].

Wodschow HZ, Jensen NJ, Desirée Nilsson MS, Rungby J.

Ugeskr Laeger. 2018 Dec 17;180(51). pii: V08180566. Danish.

PMID:
30618361
10.

Growth hormone signaling and action in obese versus lean human subjects.

Høgild ML, Bak AM, Pedersen SB, Rungby J, Frystyk J, Møller N, Jessen N, Jørgensen JOL.

Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E333-E344. doi: 10.1152/ajpendo.00431.2018. Epub 2018 Dec 21.

PMID:
30576246
11.

Hypercortisolism in Newly Diagnosed Type 2 Diabetes: A Prospective Study of 384 Newly Diagnosed Patients.

Steffensen C, Dekkers OM, Lyhne J, Pedersen BG, Rasmussen F, Rungby J, Poulsen PL, Jørgensen JOL.

Horm Metab Res. 2019 Jan;51(1):62-68. doi: 10.1055/a-0809-3647. Epub 2018 Dec 6.

PMID:
30522146
12.

Different mechanisms involved in liraglutide and glucagon-like peptide-1 vasodilatation in rat mesenteric small arteries.

Bangshaab M, Gutierrez A, Huynh KD, Knudsen JS, Arcanjo DDR, Petersen AG, Rungby J, Gejl M, Simonsen U.

Br J Pharmacol. 2019 Feb;176(3):386-399. doi: 10.1111/bph.14534. Epub 2018 Dec 9.

PMID:
30403290
13.

Prolonged fasting-induced metabolic signatures in human skeletal muscle of lean and obese men.

Bak AM, Vendelbo MH, Christensen B, Viggers R, Bibby BM, Rungby J, Jørgensen JOL, Møller N, Jessen N.

PLoS One. 2018 Sep 5;13(9):e0200817. doi: 10.1371/journal.pone.0200817. eCollection 2018.

14.

Elevated levels of 8-oxoGuo and 8-oxodG in individuals with severe mental illness - An autopsy-based study.

Christensen MR, Poulsen HE, Henriksen T, Weimann A, Ellervik C, Lynnerup N, Rungby J, Banner J.

Free Radic Biol Med. 2018 Oct;126:372-378. doi: 10.1016/j.freeradbiomed.2018.08.029. Epub 2018 Aug 23.

PMID:
30145229
15.

Detection of Glycan Shedding in the Blood: New Class of Multiple Sclerosis Biomarkers?

DellaValle B, Manresa-Arraut A, Hasseldam H, Stensballe A, Rungby J, Larsen A, Hempel C.

Front Immunol. 2018 Jun 4;9:1254. doi: 10.3389/fimmu.2018.01254. eCollection 2018.

16.

Establishing post mortem criteria for the metabolic syndrome: an autopsy based cross-sectional study.

Christensen MR, Bugge A, Malik ME, Thomsen JL, Lynnerup N, Rungby J, Banner J.

Diabetol Metab Syndr. 2018 Apr 25;10:36. doi: 10.1186/s13098-018-0339-0. eCollection 2018.

17.

Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool.

Stidsen JV, Henriksen JE, Olsen MH, Thomsen RW, Nielsen JS, Rungby J, Ulrichsen SP, Berencsi K, Kahlert JA, Friborg SG, Brandslund I, Nielsen AA, Christiansen JS, Sørensen HT, Olesen TB, Beck-Nielsen H.

Diabetes Metab Res Rev. 2018 Jul;34(5):e3005. doi: 10.1002/dmrr.3005. Epub 2018 Apr 26.

PMID:
29697198
18.

Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile.

Christensen DH, Nicolaisen SK, Berencsi K, Beck-Nielsen H, Rungby J, Friborg S, Brandslund I, Christiansen JS, Vaag A, Sørensen HT, Nielsen JS, Thomsen RW.

BMJ Open. 2018 Apr 7;8(4):e017273. doi: 10.1136/bmjopen-2017-017273.

19.

Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke: A Systematic Review based on Pre-Clinical Studies.

Marlet IR, Ölmestig JNE, Vilsbøll T, Rungby J, Kruuse C.

Basic Clin Pharmacol Toxicol. 2018 Jun;122(6):559-569. doi: 10.1111/bcpt.12974. Epub 2018 Mar 15. Review.

20.

No Impact of Pre-existing Cardiovascular Disease on Prescribing Patterns of Sulphonylureas in Denmark - A Registry-based Nationwide Study.

Nilsson M, Rungby J, Lassota N, Jørgensen AD, Ibsen R, Kjellberg J.

Basic Clin Pharmacol Toxicol. 2018 Jun;122(6):606-611. doi: 10.1111/bcpt.12961. Epub 2018 Feb 23.

21.

Prevalence of cardiovascular disease and evaluation of standard of care in type 2 diabetes: a nationwide study in primary care.

Rungby J, Schou M, Warrer P, Ytte L, Andersen GS.

Cardiovasc Endocrinol. 2017 Dec;6(4):145-151. doi: 10.1097/XCE.0000000000000135. Epub 2017 Oct 31.

22.

The effects of incretin hormones on cerebral glucose metabolism in health and disease.

Nilsson M, Gjedde A, Brock B, Gejl M, Rungby J.

Neuropharmacology. 2018 Jul 1;136(Pt B):243-250. doi: 10.1016/j.neuropharm.2017.12.031. Epub 2017 Dec 20. Review.

PMID:
29274367
23.

Blood-Brain Glucose Transfer in Alzheimer's disease: Effect of GLP-1 Analog Treatment.

Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A.

Sci Rep. 2017 Dec 13;7(1):17490. doi: 10.1038/s41598-017-17718-y.

24.

Effects of hypoglycaemia on working memory and regional cerebral blood flow in type 1 diabetes: a randomised, crossover trial.

Gejl M, Gjedde A, Brock B, Møller A, van Duinkerken E, Haahr HL, Hansen CT, Chu PL, Stender-Petersen KL, Rungby J.

Diabetologia. 2018 Mar;61(3):551-561. doi: 10.1007/s00125-017-4502-1. Epub 2017 Nov 29.

25.

Early-onset type 2 diabetes: Age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes-Results from the DD2 study.

Bo A, Thomsen RW, Nielsen JS, Nicolaisen SK, Beck-Nielsen H, Rungby J, Sørensen HT, Hansen TK, Søndergaard J, Friborg S, Lauritzen T, Maindal HT.

Diabetes Metab Res Rev. 2018 Mar;34(3). doi: 10.1002/dmrr.2968. Epub 2017 Dec 21.

PMID:
29172021
26.

Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.

Gedebjerg A, Almdal TP, Berencsi K, Rungby J, Nielsen JS, Witte DR, Friborg S, Brandslund I, Vaag A, Beck-Nielsen H, Sørensen HT, Thomsen RW.

J Diabetes Complications. 2018 Jan;32(1):34-40. doi: 10.1016/j.jdiacomp.2017.09.010. Epub 2017 Sep 19.

PMID:
29107454
27.

The effect of empagliflozin on oxidative nucleic acid modifications in patients with type 2 diabetes: protocol for a randomised, double-blinded, placebo-controlled trial.

Larsen EL, Cejvanovic V, Kjær LK, Vilsbøll T, Knop FK, Rungby J, Poulsen HE.

BMJ Open. 2017 May 9;7(5):e014728. doi: 10.1136/bmjopen-2016-014728.

28.

Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.

Nielsen RB, Egefjord L, Angleys H, Mouridsen K, Gejl M, Møller A, Brock B, Brændgaard H, Gottrup H, Rungby J, Eskildsen SF, Østergaard L.

Alzheimers Dement. 2017 Oct;13(10):1143-1153. doi: 10.1016/j.jalz.2017.02.007. Epub 2017 Mar 23.

PMID:
28343848
29.

Expression Patterns and Correlations with Metabolic Markers of Zinc Transporters ZIP14 and ZNT1 in Obesity and Polycystic Ovary Syndrome.

Maxel T, Svendsen PF, Smidt K, Lauridsen JK, Brock B, Pedersen SB, Rungby J, Larsen A.

Front Endocrinol (Lausanne). 2017 Mar 2;8:38. doi: 10.3389/fendo.2017.00038. eCollection 2017.

30.

High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex.

Lauridsen JK, Olesen RH, Vendelbo J, Hyde TM, Kleinman JE, Bibby BM, Brock B, Rungby J, Larsen A.

Transl Psychiatry. 2017 Feb 28;7(2):e1044. doi: 10.1038/tp.2016.259.

31.

Oral Administration of Sitagliptin Activates CREB and Is Neuroprotective in Murine Model of Brain Trauma.

DellaValle B, Brix GS, Brock B, Gejl M, Rungby J, Larsen A.

Front Pharmacol. 2016 Dec 1;7:450. eCollection 2016.

32.

Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats.

DellaValle B, Brix GS, Brock B, Gejl M, Landau AM, Møller A, Rungby J, Larsen A.

Front Pharmacol. 2016 Nov 18;7:433. eCollection 2016.

33.

Increasing BMI is associated with reduced expression of P-glycoprotein (ABCB1 gene) in the human brain with a stronger association in African Americans than Caucasians.

Vendelbo J, Olesen RH, Lauridsen JK, Rungby J, Kleinman JE, Hyde TM, Larsen A.

Pharmacogenomics J. 2018 Jan;18(1):121-126. doi: 10.1038/tpj.2016.74. Epub 2016 Nov 29.

34.

Nationwide trends in glucose-lowering drug use, Denmark, 1999-2014.

Christensen DH, Rungby J, Thomsen RW.

Clin Epidemiol. 2016 Oct 14;8:381-387. eCollection 2016.

35.

[Sodium-glucose cotransporter 2 (SGLT-2) inhibitors for patients with Type 2 diabetes].

Røder ME, Storgaard H, Rungby J, Knop FK, Vilsbøll T.

Ugeskr Laeger. 2016 Sep 19;178(38). pii: V05160310. Review. Danish.

PMID:
27649712
36.

Rates of Community-based Antibiotic Prescriptions and Hospital-treated Infections in Individuals With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study, 2004-2012.

Mor A, Berencsi K, Nielsen JS, Rungby J, Friborg S, Brandslund I, Christiansen JS, Vaag A, Beck-Nielsen H, Sørensen HT, Thomsen RW.

Clin Infect Dis. 2016 Aug 15;63(4):501-11. doi: 10.1093/cid/ciw345. Epub 2016 Jun 26.

PMID:
27353662
37.

Obesity and age-related alterations in the gene expression of zinc-transporter proteins in the human brain.

Olesen RH, Hyde TM, Kleinman JE, Smidt K, Rungby J, Larsen A.

Transl Psychiatry. 2016 Jun 14;6(6):e838. doi: 10.1038/tp.2016.83.

38.

Vagotomy and subsequent development of diabetes - A nested case-control study.

Starup-Linde J, Gejl M, Borghammer P, Knop FK, Gregersen S, Rungby J, Vestergaard P.

Metabolism. 2016 Jul;65(7):954-60. doi: 10.1016/j.metabol.2016.04.002. Epub 2016 Apr 13.

PMID:
27282866
39.

In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial.

Gejl M, Gjedde A, Egefjord L, Møller A, Hansen SB, Vang K, Rodell A, Brændgaard H, Gottrup H, Schacht A, Møller N, Brock B, Rungby J.

Front Aging Neurosci. 2016 May 24;8:108. doi: 10.3389/fnagi.2016.00108. eCollection 2016.

40.

Differential regulation of lipid and protein metabolism in obese vs. lean subjects before and after a 72-h fast.

Bak AM, Møller AB, Vendelbo MH, Nielsen TS, Viggers R, Rungby J, Pedersen SB, Jørgensen JO, Jessen N, Møller N.

Am J Physiol Endocrinol Metab. 2016 Jul 1;311(1):E224-35. doi: 10.1152/ajpendo.00464.2015. Epub 2016 May 31.

41.

Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetes.

Steffensen C, Thomsen HH, Dekkers OM, Christiansen JS, Rungby J, Jørgensen JO.

Clin Endocrinol (Oxf). 2016 Aug;85(2):202-6. doi: 10.1111/cen.13071. Epub 2016 May 2.

PMID:
27028214
42.

The zinc transporter ZNT3 co-localizes with insulin in INS-1E pancreatic beta cells and influences cell survival, insulin secretion capacity, and ZNT8 expression.

Smidt K, Larsen A, Brønden A, Sørensen KS, Nielsen JV, Praetorius J, Martensen PM, Rungby J.

Biometals. 2016 Apr;29(2):287-98. doi: 10.1007/s10534-016-9915-7. Epub 2016 Feb 11.

PMID:
26867900
43.

GLP-1 and Amylin in the Treatment of Obesity.

Jorsal T, Rungby J, Knop FK, Vilsbøll T.

Curr Diab Rep. 2016 Jan;16(1):1. doi: 10.1007/s11892-015-0693-3. Review.

PMID:
26699764
44.

Gene expression of the zinc transporter ZIP14 (SLC39a14) is affected by weight loss and metabolic status and associates with PPARγ in human adipose tissue and 3T3-L1 pre-adipocytes.

Maxel T, Smidt K, Larsen A, Bennetzen M, Cullberg K, Fjeldborg K, Lund S, Pedersen SB, Rungby J.

BMC Obes. 2015 Nov 24;2:46. doi: 10.1186/s40608-015-0076-y. eCollection 2015.

45.

Association of parental history of type 2 diabetes with age, lifestyle, anthropometric factors, and clinical severity at type 2 diabetes diagnosis: results from the DD2 study.

Svensson E, Berencsi K, Sander S, Mor A, Rungby J, Nielsen JS, Friborg S, Brandslund I, Christiansen JS, Vaag A, Beck-Nielsen H, Sørensen HT, Thomsen RW.

Diabetes Metab Res Rev. 2016 Mar;32(3):308-15. doi: 10.1002/dmrr.2721. Epub 2015 Nov 6.

PMID:
26408959
46.

Reduced CD300LG mRNA tissue expression, increased intramyocellular lipid content and impaired glucose metabolism in healthy male carriers of Arg82Cys in CD300LG: a novel genometabolic cross-link between CD300LG and common metabolic phenotypes.

Støy J, Kampmann U, Mengel A, Magnusson NE, Jessen N, Grarup N, Rungby J, Stødkilde-Jørgensen H, Brandslund I, Christensen C, Hansen T, Pedersen O, Møller N.

BMJ Open Diabetes Res Care. 2015 Aug 26;3(1):e000095. doi: 10.1136/bmjdrc-2015-000095. eCollection 2015.

47.

Detection of Patients at High Risk of Medication Errors: Development and Validation of an Algorithm.

Saedder EA, Lisby M, Nielsen LP, Rungby J, Andersen LV, Bonnerup DK, Brock B.

Basic Clin Pharmacol Toxicol. 2016 Feb;118(2):143-9. doi: 10.1111/bcpt.12473. Epub 2015 Sep 22.

48.

Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment.

Storgaard H, Bagger JI, Knop FK, Vilsbøll T, Rungby J.

Basic Clin Pharmacol Toxicol. 2016 Feb;118(2):168-70. doi: 10.1111/bcpt.12457. Epub 2015 Sep 11.

49.

Prescribing practices and clinical predictors of glucose-lowering therapy within the first year in people with newly diagnosed Type 2 diabetes.

Mor A, Berencsi K, Svensson E, Rungby J, Nielsen JS, Friborg S, Brandslund I, Christiansen JS, Vaag A, Beck-Nielsen H, Sørensen HT, Thomsen RW.

Diabet Med. 2015 Dec;32(12):1546-54. doi: 10.1111/dme.12819. Epub 2015 Jul 3.

PMID:
26032247
50.

Medication Review and Patient Outcomes in an Orthopedic Department: A Randomized Controlled Study.

Lisby M, Bonnerup DK, Brock B, Gregersen PA, Jensen J, Larsen ML, Rungby J, Sonne J, Mainz J, Nielsen LP.

J Patient Saf. 2018 Jun;14(2):74-81. doi: 10.1097/PTS.0000000000000173.

PMID:
25742062

Supplemental Content

Loading ...
Support Center